Skip to content
Open access

Multi-level thromboinflammatory activation after TAVR: systemic, cellular, and platelet transcriptomic changes

Oct 2026 · European Heart Journal · 0 citations

TL;DR

TAVR induces a coordinated thromboinflammatory response across systemic, cellular, and transcriptomic levels, characterized by systemic coagulation and inflammatory activation, platelet phenotypic alterations, and transcriptional enrichment of platelet activation pathways.

Abstract

Transcatheter aortic valve replacement (TAVR) induces a thromboinflammatory response characterized by hypercoagulability and dynamic platelet alterations. The integrated mechanisms underlying these changes remain incompletely defined. To comprehensively characterize periprocedural hemostatic and inflammatory changes after TAVR across systemic, cellular, and transcriptomic levels. In this prospective single-center study, patients undergoing TAVR were enrolled between September 2022 and July 2024. Blood samples were obtained on the day of the procedure (T0; prior to valve implantation) and at hospital discharge (T1; median 3.5 days, IQR 2–4 days). At both time points, soluble biomarkers were assessed by routine laboratory testing, cellular phenotype by flow cytometry (FACS), and isolated platelets underwent RNA sequencing. Soluble biomarkers were assessed in 102 consecutive TAVR patients, with FACS and transcriptomic analysis in a sub-cohort of 32. TAVR induced a pronounced systemic increase in markers of coagulation and inflammation. The most relevant changes were observed for D-dimers (medianΔ 0.67 mg/L [IQRΔ 0.44–1.07]; p = 0.001), von Willebrand factor activity (medianΔ 87% p < 0.0001), fibrinogen (medianΔ 125 mg/dL; p < 0.0001), Il-6 (medianΔ 19.70 ng/l [IQRΔ 10.80–35.25]; p < 0.0001 and Troponin T medianΔ 43.20 ng/l;p < 0.0001, consistent with acute coagulation and inflammatory activation with myocardial injury. At cellular level, platelet count declined (medianΔ −27 × 10³/µL [−54.5 to −5.5]; p < 0.0001), accompanied by reduced GPIIb/IIIa (ΔgeoMFI −275 a.u.; p < 0.0001) and CD62P expression (ΔgeoMFI −98 a.u.; p =0.003), and increased platelet–neutrophil aggregates (CD42a+CD15+, ΔgeoMFI 377.0 a.u. p = 0.036), reflecting platelet phenotypic alteration and enhanced platelet–immune interaction. At the transcriptomic level, RNA sequencing identified 188 upregulated and 508 downregulated differentially expressed transcripts.Gene set enrichment analysis demonstrated upregulation of platelet activation, aggregation, and hemostasis pathways. Over-representation analysis confirmed enrichment of platelet activation–associated genes, including DMTN, FCER1G, MMRN1, SELP, and FUNDC2. TAVR induces a coordinated thromboinflammatory response across systemic, cellular, and transcriptomic levels, characterized by systemic coagulation and inflammatory activation, platelet phenotypic alterations, and transcriptional enrichment of platelet activation pathways. Together, these findings provide mechanistic insight into the acute thromboinflammatory milieu associated with the procedure.Periprocedural changes of systemic parametersFor image description, please refer to the figure legend and surrounding text.Periprocedural changes of cell based markersFor image description, please refer to the figure legend and surrounding text.

Read PDF

Similar papers

Open access Oct 2026

PO050 | HEMOSTATIC AND FIBRINOLYTIC PROFILES IN PATIENTS UNDERGOING TAVI: PRELIMINARY RESULTS ON HOMOCYSTEINE, D-DIMER, AND CLOT LYSIS TIME

Background and aims. Transcatheter Aortic Valve Implantation (TAVI) is the treatment of choice for patients with severe symptomatic aortic stenosis, particularly those with high frailty and multiple comorbidities. Despite its minimally invasive nature, TAVI induces systemic inflammation and mechanical stress, potential...

Giulia Ciarrocca Taranta · 0 citations
Open access Nov 2026

Assessment of circulating biomarkers in patients with chronic thromboembolic pulmonary hypertension before and after surgical treatment

A positive correlation was demonstrated between Δ t-PA and the magnitude of the reduction in CTEPH severity markers, such as PVR and the RV/LV ratio, such as PVR and the RV/LV ratio, as well as markers of hemostasis and fibrinolysis.

M. Simakova, Y. Karpova, A. M. Osadchii et al. · 0 citations
Open access Oct 2026

Multipathway Biomarker Profiling of Immunothrombosis in Moderate and Severe COVID-19.

Background/Objectives: Coronavirus disease 2019 (COVID-19) is associated with immunothrombosis involving endothelial dysfunction and coagulation activation. We aimed to compare biomarkers spanning multiple immunothrombotic pathways between patients with moderate and severe COVID-19 at baseline and according to clinical...

Giovanni Bousquet, R. Lacroix, L. Pahus et al. · 0 citations
Open access Oct 2026

Complement activation characterizes a high mortality subgroup in pulmonary embolism: An observational proteomic study.

BACKGROUND Complement and coagulation pathways are mechanistically linked in thromboinflammation, yet the contribution of complement activation to pulmonary embolism (PE) pathophysiology and risk stratification remains largely unexplored. We used plasma proteomics and functional assays to identify thromboinflammatory e...

A. Tenhunen, O. Eriksson, Bo Nilsson et al. · 0 citations
Open access Oct 2026

PO117 | LONGITUDINAL THROMBIN GENERATION PROFILING IN A PATIENT WITH SEVERE HEMOPHILIA A DURING ANTITHROMBIN-LOWERING THERAPY, CANCER, AND MAJOR SURGERY

Background and aims. Thrombin generation (TG) represents one of the few functional assays available to assess the hemostatic balance in patients with hemophilia receiving non-replacement therapies. However, longitudinal data over extended periods and during major biological stressors such as cancer and surgery are limi...

C. Simion · 0 citations
Open access Oct 2026

PO049 | WHOLE-BLOOD THROMBIN GENERATION ASSAY REVEALS HYPERCOAGULABLE STATE IN SICKLE CELL DISEASE IN STEADY STATE AND CORRELATES WITH CLINICAL EVENTS

Background and Aims. Sickle cell disease (SCD) is a systemic condition characterized by vaso-occlusive crises (VOC), which underlie acute complications and chronic organ damage. The pathophysiology of VOC is multifactorial and includes chronic hypercoagulability. Whole blood thrombin generation (WB-TG) with and without...

Angela Bravin · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.